Barr Plans Move To OTC Market With Plan B Emergency Contraceptive
This article was originally published in The Tan Sheet
Executive Summary
Barr Laboratories will continue to pursue an Rx-to-OTC switch for the emergency contraceptive Plan B following its planned acquisition of the product